Journal
CELL REPORTS
Volume 32, Issue 8, Pages -Publisher
CELL PRESS
DOI: 10.1016/j.celrep.2020.108064
Keywords
-
Categories
Funding
- Marshall Plan Foundation
- Austrian Federal Ministry for Education
- National Institutes of Health (NIH) [R01ES015339, R35-ES028374, R01-CA226898, U54-CA112967]
- Charles and Marjorie Holloway Foundation
- MIT Center for Precision Cancer Medicine
- Starr Cancer Consortium [I9-A9-077]
- Koch Institute Support (core) Grant from the National Cancer Institute [P30-CA14051]
Ask authors/readers for more resources
RNA-binding proteins (RBPs) play critical roles in regulating gene expression by modulating splicing, RNA stability, and protein translation. Stimulus-induced alterations in RBP function contribute to global changes in gene expression, but identifying which RBPs are responsible for the observed changes remains an unmet need. Here, we present Transite, a computational approach that systematically infers RBPs influencing gene expression through changes in RNA stability and degradation. As a proof of principle, we apply Transite to RNA expression data from human patients with non-small-cell lung cancer whose tumors were sampled at diagnosis or after recurrence following treatment with platinum-based chemotherapy. Transite implicates known RBP regulators of the DNA damage response and identifies hnRNPC as a new modulator of chemotherapeutic resistance, which we subsequently validated experimentally. Transite serves as a framework for the identification of RBPs that drive cell-state transitions and adds additional value to the vast collection of publicly available gene expression datasets.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available